DICER1 rs1060503640: What Your Genotype Means

What each genotype means

What Is This Variant and Where Is It?

The rs1060503640 variant is a specific change in the DNA sequence of the DICER1 gene. In human genetics, a Single Nucleotide Polymorphism (SNP) or variant represents a difference in a single letter of the genetic code. The DICER1 gene itself is located on chromosome 14 and provides the instructions for building the Dicer protein. This protein acts like a biological editor, playing a vital role in regulating how other genes are expressed by processing molecules called microRNAs (miRNAs). Because DICER1 is so central to how cells control their internal activities—such as how they grow, divide, and mature—variants in this gene can disrupt the delicate balance of gene regulation. When the Dicer protein is not functioning as intended due to a genetic alteration, it may hinder the cell's ability to properly manage these processes, which is a known factor in various tumor predisposition syndromes.

Understanding the DICER1 Gene and Health

The DICER1 gene acts as a master controller for cellular instructions. By producing Dicer, the body ensures that microRNAs are created effectively. These microRNAs are essentially off-switches for other genes; they bind to messenger RNA (mRNA) to prevent it from being translated into proteins or to break the mRNA down entirely. When a person carries a pathogenic variant in DICER1, they may produce an abnormally short or non-functional Dicer protein. This can lead to a condition known as DICER1 syndrome. It is important to emphasize that while this syndrome predisposes individuals to a higher risk of developing specific tumors—such as pleuropulmonary blastoma in the lungs, cystic nephroma in the kidneys, or certain ovarian and thyroid growths—most people who carry such a variant never develop a tumor. The condition typically follows an autosomal dominant inheritance pattern, meaning a single altered copy of the gene is enough to increase this risk.

Research and Evidence Strength

The association between DICER1 variants and cancer predisposition is well-documented in medical literature, though evidence for specific rare variants like rs1060503640 can be categorized as limited depending on the clinical context. Research consistently demonstrates that DICER1 syndrome is a heterogeneous disorder, meaning the clinical presentation can vary widely even among family members. The risk of developing a neoplasm is statistically higher than in the general population, with studies suggesting that while the risk of tumors before age 10 is relatively low, it increases as individuals age. Current research focuses heavily on the two-hit hypothesis, where a germline (inherited) mutation in DICER1 is often followed by a second, somatic (acquired) mutation in the same gene within specific tissues. This second event is what often triggers the development of a tumor. Because of the complexity and rarity of these events, clinicians view these variants with high attention to assess individual risk profiles.

What You Can and Cannot Do

This information is for educational purposes and should not be used for self-diagnosis or medical decision-making. If you have concerns about your genetic health or family history, you should speak with a board-certified genetic counselor or a physician specializing in cancer genetics. They can interpret your results in the context of your specific health history, determine if further clinical testing is appropriate, and discuss potential surveillance strategies if necessary. Do not use this information to initiate or change any medical treatment; all clinical decisions must be made in consultation with your healthcare team.

Frequently asked questions

Sources & further reading

Related variants in DICER1